840635P
12:0 PA
Manufacturer: Sigma Aldrich
CAS Number: 108321-06-8
Synonym(S): 1,2-didodecanoyl-sn-glycero-3-phosphate (sodium salt); DLPA; PA(12:0/12:0)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 840635P-25-MG | In Stock | ₹ 12,881.75 |
| 200 MG | 840635P-200-MG | In Stock | ₹ 38,331.33 |
840635P - 25 MG
In Stock
Quantity
1
Base Price: ₹ 12,881.75
GST (18%): ₹ 2,318.715
Total Price: ₹ 15,200.465
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 200 mg (840635P-200mg)pkg of 1 × 25 mg (840635P-25mg)
manufacturer/tradename
Avanti Polar Lipids 840635P
lipid type
phospholipidscardiolipins
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(O)=O)(OC(CCCCCCCCCCC)=O)COC(CCCCCCCCCCC)=O.[Na+]
InChI
1S/C27H53O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-26(28)33-23-25(24-34-36(30,31)32)35-27(29)22-20-18-16-14-12-10-8-6-4-2;/h25H,3-24H2,1-2H3,(H2,30,31,32);/q;+1/p-1/t25-;/m1./s1
InChI key
CIOHBYXGWWPOIS-VQIWEWKSSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 1,2-Dilauroyl-sn-glycero-3-phosphate sodium | ChemScene | ₹ 8,384.88 - ₹ 42,352.20 | |
 | 108321-06-8 | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHATE(SODIUMSALT) | A2B Chem | ₹ 3,764.64 - ₹ 13,604.04 |
Related Products
Description
- General description: 12:0 PA (1,2-dilauroyl-sn-glycero-3-phosphate) is a sodium salt of modified lipid, wherein C-1, C-2 of glycerol is substituted with didodecanoyl and C-3 of glycerol is substituted with phosphatidic acid group.
- Application: 12:0 PA (1,2-dilauroyl-sn-glycero-3-phosphate (sodium salt)) has been used as an internal lipid standard in the matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FT-ICR MS) analysis.[1] It may be used as a lipid standard: for the quantification of phospholipids by high-performance liquid chromatography coupled to tandem mass spectrometryelectrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS)[2] for the quantification of lipids in cold-pressed rapeseed oils based on direct infusion electrospray ionization tandem mass spectrometry[3] in liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis[4]
- Biochem/physiol Actions: Phosphatidic acid (PA) might serve as a modulator of phagocyte respiratory burst.[5]
- Packaging: 5 mL Amber Glass Screw Cap Vial (840635P-200mg)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 200 mg (840635P-200mg)pkg of 1 × 25 mg (840635P-25mg)
manufacturer/tradename: Avanti Polar Lipids 840635P
lipid type: phospholipidscardiolipins
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O)=O)(OC(CCCCCCCCCCC)=O)COC(CCCCCCCCCCC)=O.[Na+]
InChI: 1S/C27H53O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-26(28)33-23-25(24-34-36(30,31)32)35-27(29)22-20-18-16-14-12-10-8-6-4-2;/h25H,3-24H2,1-2H3,(H2,30,31,32);/q;+1/p-1/t25-;/m1./s1
InChI key: CIOHBYXGWWPOIS-VQIWEWKSSA-M
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 200 mg (840635P-200mg)pkg of 1 × 25 mg (840635P-25mg)
manufacturer/tradename:
Avanti Polar Lipids 840635P
lipid type:
phospholipidscardiolipins
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O)=O)(OC(CCCCCCCCCCC)=O)COC(CCCCCCCCCCC)=O.[Na+]
InChI:
1S/C27H53O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-26(28)33-23-25(24-34-36(30,31)32)35-27(29)22-20-18-16-14-12-10-8-6-4-2;/h25H,3-24H2,1-2H3,(H2,30,31,32);/q;+1/p-1/t25-;/m1./s1
InChI key:
CIOHBYXGWWPOIS-VQIWEWKSSA-M
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840857C-25mg)pkg of 2 × 4 mL (840857C-200mg)pkg of 5 × 4 mL (840857C-500mg)
manufacturer/tradename: Avanti Polar Lipids 840857C
lipid type: phospholipidscardiolipins
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1
InChI key: __
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 2.5 mL (840857C-25mg)pkg of 2 × 4 mL (840857C-200mg)pkg of 5 × 4 mL (840857C-500mg)
manufacturer/tradename:
Avanti Polar Lipids 840857C
lipid type:
phospholipidscardiolipins
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI:
1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1
InChI key:
__
Assay: >99% (TLC)
form: powder
packaging: pkg of 2 × 100 mg (840857P-200mg)pkg of 5 × 100 mg (840857P-500mg)pkg of 1 × 25 mg (840857P-25mg)
manufacturer/tradename: Avanti Polar Lipids
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1
InChI key: __
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 2 × 100 mg (840857P-200mg)pkg of 5 × 100 mg (840857P-500mg)pkg of 1 × 25 mg (840857P-25mg)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI:
1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1
InChI key:
__
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840860C-25mg)
manufacturer/tradename: Avanti Polar Lipids 840860C
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C41H69O8P.Na/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2;/h5,7,11,13,17-18,20-21,24,26,30,32,39H,3-4,6,8-10,12,14-16,19,22-23,25,27-29,31,33-38H2,1-2H3,(H2,44,45,46);/q;+1/p-1/b7-5-,13-11-,18-17-,21-20-,26-24-,32-30-;/t39-;/m1./s1
InChI key: __
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 2.5 mL (840860C-25mg)
manufacturer/tradename:
Avanti Polar Lipids 840860C
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI:
1S/C41H69O8P.Na/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2;/h5,7,11,13,17-18,20-21,24,26,30,32,39H,3-4,6,8-10,12,14-16,19,22-23,25,27-29,31,33-38H2,1-2H3,(H2,44,45,46);/q;+1/p-1/b7-5-,13-11-,18-17-,21-20-,26-24-,32-30-;/t39-;/m1./s1
InChI key:
__